These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 8828808)

  • 21. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.
    Eldor A; Bar-Ner M; Yahalom J; Fuks Z; Vlodavsky I
    Semin Thromb Hemost; 1987 Oct; 13(4):475-88. PubMed ID: 3321438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.
    Yahalom J; Fibach E; Bar-Tana R; Fuks Z; Vlodavsky I
    Leuk Res; 1988; 12(9):711-7. PubMed ID: 2973542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; Nicolson GL
    Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human prostate carcinoma cells produce extracellular heparanase.
    Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
    J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
    Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
    Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A solid-phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity.
    Nakajima M; Irimura T; Nicolson GL
    Anal Biochem; 1986 Aug; 157(1):162-71. PubMed ID: 3766958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
    Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
    Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase.
    Bartlett MR; Underwood PA; Parish CR
    Immunol Cell Biol; 1995 Apr; 73(2):113-24. PubMed ID: 7797231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
    Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
    Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate.
    Sewell RF; Brenchley PE; Mallick NP
    Biochem J; 1989 Dec; 264(3):777-83. PubMed ID: 2533499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production.
    Marchetti D; Menter D; Jin L; Nakajima M; Nicolson GL
    Int J Cancer; 1993 Oct; 55(4):692-9. PubMed ID: 8407001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet heparanase in vascular responses to xenotransplantation.
    Dempsey LA; Plummer TB; Coombes S; Platt JL
    Transplant Proc; 2000 Aug; 32(5):972. PubMed ID: 10936304
    [No Abstract]   [Full Text] [Related]  

  • 33. Connective tissue activation XXXVIII: heparin/heparanase activity of human platelets resides in a high molecular weight protein, not in connective tissue activating peptide III.
    Castor CW; Kotlyar A; Edwards BE
    J Rheumatol; 2002 Nov; 29(11):2337-44. PubMed ID: 12415589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoselection of GRP94/endoplasmin from a KNRK cell-specific lambda gt11 library using antibodies directed against a putative heparanase amino-terminal peptide.
    De Vouge MW; Yamazaki A; Bennett SA; Chen JH; Shwed PS; Couture C; Birnboim HC
    Int J Cancer; 1994 Jan; 56(2):286-94. PubMed ID: 8314313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.
    Hulett MD; Freeman C; Hamdorf BJ; Baker RT; Harris MJ; Parish CR
    Nat Med; 1999 Jul; 5(7):803-9. PubMed ID: 10395326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification, characterization, and mode of action of a rhamnogalacturonan hydrolase from Irpex lacteus, tolerant to an acetylated substrate.
    Normand J; Ralet MC; Thibault JF; Rogniaux H; Delavault P; Bonnin E
    Appl Microbiol Biotechnol; 2010 Mar; 86(2):577-88. PubMed ID: 19862512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-speed gel-permeation chromatography of glycosaminoglycans: its application to the analysis of heparan sulfate of embryonic carcinoma and its degradation products by tumor cell-derived heparanase.
    Irimura T; Nakajima M; Di Ferrante N; Nicolson GL
    Anal Biochem; 1983 Apr; 130(2):461-8. PubMed ID: 6223541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of fatty acid cyclooxygenase from human platelets.
    Ho PP; Towner RD; Esterman MA
    Prep Biochem; 1980; 10(5):597-613. PubMed ID: 6777769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An alpha-glucuronidase of Schizophyllum commune acting on polymeric xylan.
    Tenkanen M; Siika-aho M
    J Biotechnol; 2000 Mar; 78(2):149-61. PubMed ID: 10725538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratinocytes-associated chemokines and enzymatically quiescent heparanase induce the binding of resting CD4+ T cells.
    Hershkoviz R; Marikovsky M; Gilat D; Lider O
    J Invest Dermatol; 1996 Feb; 106(2):243-8. PubMed ID: 8601723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.